Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 76.36% is in line with its 5-year average of 74.01%, near the high end of its 5-year range (22.16%–81.84%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.61% above its 12-month average of 75.89%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 76.36%.
DEBT TO ASSETS RATIO
76.36%
DEBT TO ASSETS RATIO AVG TTM
75.89%
DEBT TO ASSETS RATIO AVG 3Y
75.64%
DEBT TO ASSETS RATIO AVG 5Y
74.01%
DEBT TO ASSETS RATIO AVG 10Y
51.21%
DEBT TO ASSETS RATIO AVG 15Y
39.08%
DEBT TO ASSETS RATIO AVG 20Y
31.72%
CURRENT VS TTM AVG
+0.61%
CURRENT VS 3Y AVG
+0.95%
CURRENT VS 5Y AVG
+3.17%
CURRENT VS 10Y AVG
+49.11%
CURRENT VS 15Y AVG
+95.40%
CURRENT VS 20Y AVG
+140.77%
SECTOR MEDIAN · HEALTHCARE
0.12%
median of 430 covered companies
CURRENT VS SECTOR MEDIAN
+63532.97%
vs the sector median at left
Alphatec Holdings, Inc.
Market Cap
$1.65B
Debt to Assets Ratio
76.36%
TTM Avg
75.89%
3Y Avg
75.64%
5Y Avg
74.01%
Market Cap
$1.65B
Debt to Assets Ratio
0.22%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.71B
Debt to Assets Ratio
0.44%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.76B
Debt to Assets Ratio
0.26%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.52B
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.78B
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.78B
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | $1.65B | 76.36% | 75.89% | 75.64% | 74.01% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 0.22% | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 0.44% | N/A | N/A | N/A |
| Certara, Inc. (CERT)vs › | $1.57B | 0.21% | N/A | N/A | N/A |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 0.26% | N/A | N/A | N/A |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 0.25% | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.52B | 0.00% | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | 0.09% | N/A | N/A | N/A |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | 0.11% | N/A | N/A | N/A |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
Debt/Assets
76.4%
Debt/Equity
N/A
Current Ratio
1.89
Interest Coverage
-3.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 76.36% |
| 2026-03-31 | 75.43% |
| 2025-12-31 | 78.35% |
| 2025-09-30 | 75.09% |
| 2025-06-30 | 74.23% |
| 2025-03-31 | 74.00% |
| 2024-12-31 | 78.63% |
| 2024-09-30 | 75.59% |
| 2024-06-30 | 72.28% |
| 2024-03-31 | 69.81% |
| 2023-12-31 | 67.27% |
| 2023-09-30 | 80.27% |
| 2023-06-30 | 77.62% |
| 2023-03-31 | 81.84% |
| 2022-12-31 | 75.99% |
| 2022-09-30 | 76.19% |
| 2022-06-30 | 70.16% |
| 2022-03-31 | 64.95% |
| 2021-12-31 | 62.13% |
| 2021-09-30 | 59.44% |
| 2021-06-30 | 22.16% |
| 2021-03-31 | 16.36% |
| 2020-12-31 | 16.27% |
| 2020-09-30 | 43.02% |
| 2020-06-30 | 40.97% |
| 2020-03-31 | 36.31% |
| 2019-12-31 | 32.11% |
| 2019-09-30 | 1.18% |
| 2019-06-30 | 1.09% |
| 2019-03-31 | 38.59% |
| 2018-12-31 | 2.53% |
| 2018-09-30 | 30.78% |
| 2018-06-30 | 28.92% |
| 2018-03-31 | 28.99% |
| 2017-12-31 | 48.52% |
| 2017-09-30 | 50.47% |
| 2017-06-30 | 48.11% |
| 2017-03-31 | 45.56% |
| 2016-12-31 | 3.31% |
| 2016-09-30 | 43.25% |
| 2016-06-30 | 55.38% |
| 2016-03-31 | 53.94% |
| 2015-12-31 | 54.60% |
| 2015-09-30 | 53.87% |
| 2015-06-30 | 2.15% |
| 2015-03-31 | 24.83% |
| 2014-12-31 | 2.34% |
| 2014-09-30 | 22.56% |
| 2014-06-30 | 21.06% |
| 2014-03-31 | 17.68% |
| 2013-12-31 | 1.35% |
| 2013-09-30 | 1.36% |
| 2013-06-30 | 0.19% |
| 2013-03-31 | 0.34% |
| 2012-12-31 | 0.44% |
| 2012-09-30 | 10.32% |
| 2012-06-30 | 0.21% |
| 2012-03-31 | 8.31% |
| 2011-12-31 | 7.69% |
| 2011-09-30 | 0.68% |
| 2011-06-30 | 0.25% |
| 2011-03-31 | 8.66% |
| 2010-12-31 | 9.07% |
| 2010-09-30 | 8.41% |
| 2010-06-30 | 2.68% |
| 2010-03-31 | 10.30% |
| 2009-12-31 | 18.75% |
| 2009-09-30 | 18.34% |
| 2009-06-30 | 2.62% |
| 2009-03-31 | 18.58% |
| 2008-12-31 | 18.38% |
| 2008-09-30 | 11.86% |
| 2008-06-30 | 9.87% |
| 2008-03-31 | 8.66% |
| 2007-12-31 | 4.56% |
| 2007-09-30 | 4.84% |
| 2007-06-30 | 6.46% |
| 2007-03-31 | 6.03% |
| 2006-12-31 | 6.45% |
| 2006-09-30 | 5.26% |
| 2006-06-30 | 5.39% |
| 2006-03-31 | 11.80% |
| 2005-12-31 | 8.64% |
| 2004-12-31 | 49.02% |
